-
EP4083629
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4083629
| EP4083629 - NON-INVASIVE DIAGNOSTIC PREDICTION OF TREATMENT SUCCESS IN ALLERGEN SPECIFIC IMMUNOTHERAPY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.09.2023 Database last updated on 21.03.2025 | |
| Former | The application has been published Status updated on 30.09.2022 | Most recent event Tooltip | 15.09.2023 | Application deemed to be withdrawn | published on 18.10.2023 [2023/42] | Applicant(s) | For all designated states Klinikum rechts der Isar der Technischen Universität München Ismaninger Straße 22 81675 München / DE | [2022/44] | Inventor(s) | 01 /
ZISSLER, Ulrich 83376 Truchtlaching / DE | 02 /
SCHMIDT-Weber, Carsten 80939 München / DE | 03 /
SCHUBERT, Benjamin 81541 München / DE | 04 /
CHAKER, Adam 81927 München / DE | 05 /
JAKWERTH, Constanze 80997 München / DE | [2022/44] | Representative(s) | Engelhard, Markus Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22 80336 München / DE | [2022/44] | Application number, filing date | 21170702.1 | 27.04.2021 | [2022/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4083629 | Date: | 02.11.2022 | Language: | EN | [2022/44] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.10.2021 | Classification | IPC: | G01N33/68 | [2022/44] | CPC: |
G01N33/6893 (EP);
G01N2800/24 (EP);
G01N2800/52 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/44] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | NICHT-INVASIVE DIAGNOSTISCHE VORHERSAGE DES BEHANDLUNGSERFOLGS BEI EINER ALLERGENSPEZIFISCHEN IMMUNTHERAPIE | [2022/44] | English: | NON-INVASIVE DIAGNOSTIC PREDICTION OF TREATMENT SUCCESS IN ALLERGEN SPECIFIC IMMUNOTHERAPY | [2022/44] | French: | PRÉDICTION DIAGNOSTIQUE NON INVASIVE DU SUCCÈS DU TRAITEMENT EN IMMUNOTHÉRAPIE SPÉCIFIQUE AUX ALLERGÈNES | [2022/44] | Examination procedure | 03.05.2023 | Application deemed to be withdrawn, date of legal effect [2023/42] | 25.05.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2023/42] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.04.2023 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]EP3418738 (KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIV MUENCHEN [DE]) [X] 1-5,9-11,13-15 * the whole document, in particular paragraph [0012], examples 1, 6; Figure 5; Claim 1 * [I] 12; | [XAI] - ZISSLER U M ET AL, "Allergen-specific immunotherapy induces the suppressive secretoglobin 1A1 in cells of the lower airways", ALLERGY, vol. 76, no. 8, doi:10.1111/all.14756, (20210306), pages 2461 - 2474, URL: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/all.14756, XP055846776 [X] 1-7,9-11,13-15 * the whole document, in particular abstract; graphical abstract; section 1, last sentence; sections 3.2-3.4; section 4.5, last 10 lines; section 5;; figures 1-4 * [A] 8 [I] 12 DOI: http://dx.doi.org/10.1111/all.14756 | [X] - BAHMER T ET AL, "Nasal cytokine patterns in patients with asthma", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (2018), vol. 197, no. MeetingAbstracts, XP009530385 [X] 14 * first sentence of section "methods" * | [A] - SHAMJI M H ET AL, "Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper", ALLERGY, (20170801), vol. 72, no. 8, doi:10.1111/all.13138, pages 1156 - 1173, XP055492179 [A] 1-15 * "Domain v: Cytokines and chemokines" spanning pages 1161 and 1162 * DOI: http://dx.doi.org/10.1111/all.13138 | [A] - SCADDING G W ET AL, "Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge", ALLERGY, vol. 70, no. 6, doi:10.1111/all.12608, (20150406), pages 689 - 696, URL: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/all.12608, XP055846756 [A] 1-15 * the whole document, in particular abstract * DOI: http://dx.doi.org/10.1111/all.12608 | by applicant | - A.M. CHAKER et al., Journal of Allergy and Clinical Immunology, (20160000), vol. 137, pages 452 - 461 | - PFAAR et al., Allergy, (20140000), vol. 69, pages 854 - 867 | - ZISSLER UMJAKWERTH CAGUERTH FPECHTOLD L et al., "Early IL- producing B-cells and coinciding Th/Tr shifts during three year grass-pollen AIT", EBioMedicine, (20180000), vol. 36, pages 475 - 488 | - ZISSLER UMULRICH MJAKWERTH CA et al., "Biomatrix for upper and lower airway biomarkers in patients with allergic asthma.", The Journal of Allergy and Clinical Immunology, vol. 142, doi:10.1016/j.jaci.2018.07.027, pages 1980 - 1983, XP085549840 DOI: http://dx.doi.org/10.1016/j.jaci.2018.07.027 |